Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
34
MDWD Quote, Financials, Valuation and Earnings
Last price:
$17.14
Seasonality move
:
1.19%
Day range:
$16.97 - $17.85
52-week range:
$14.14 - $22.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.95x
P/B ratio:
4.41x
Volume:
78.9K
Avg. volume:
118.1K
1-year change:
-0.06%
Market cap:
$221.2M
Revenue:
$20.2M
EPS (TTM):
-$1.90
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MDWD
MediWound Ltd.
|
$2.1M | -$0.61 | 20.86% | -832.55% | $31.50 |
|
BLRX
BioLineRx Ltd.
|
$492K | -$0.77 | -95.85% | -49.07% | $20.33 |
|
CGEN
Compugen Ltd.
|
$14.3M | $0.14 | -63.51% | -2.83% | $5.80 |
|
EVGN
Evogene Ltd.
|
$275K | -$0.26 | -82.93% | -68.8% | $2.50 |
|
NNOX
Nano-X Imaging Ltd.
|
$4M | -$0.15 | 33.13% | -35.84% | $7.40 |
|
PLUR
Pluri, Inc.
|
$638K | -$0.65 | 316.67% | -79.86% | $12.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MDWD
MediWound Ltd.
|
$17.25 | $31.50 | $221.2M | -- | $0.00 | 0% | 8.95x |
|
BLRX
BioLineRx Ltd.
|
$2.95 | $20.33 | $12.8M | -- | $0.00 | 0% | 0.81x |
|
CGEN
Compugen Ltd.
|
$1.71 | $5.80 | $159.9M | 55.83x | $0.00 | 0% | 22.85x |
|
EVGN
Evogene Ltd.
|
$1.02 | $2.50 | $8.9M | -- | $0.00 | 0% | 1.43x |
|
NNOX
Nano-X Imaging Ltd.
|
$2.24 | $7.40 | $146.5M | -- | $0.00 | 0% | 11.49x |
|
PLUR
Pluri, Inc.
|
$3.74 | $12.00 | $34.6M | -- | $0.00 | 0% | 20.45x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MDWD
MediWound Ltd.
|
15.68% | 1.287 | 4.04% | 2.48x |
|
BLRX
BioLineRx Ltd.
|
36.81% | 2.493 | 69.17% | 1.84x |
|
CGEN
Compugen Ltd.
|
6.3% | 2.410 | 2.14% | 4.24x |
|
EVGN
Evogene Ltd.
|
68.82% | 1.695 | 9.67% | 4.01x |
|
NNOX
Nano-X Imaging Ltd.
|
4.79% | 1.591 | 3.26% | 3.82x |
|
PLUR
Pluri, Inc.
|
149.64% | 0.066 | 81% | 0.49x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MDWD
MediWound Ltd.
|
$896K | -$6.5M | -49.92% | -61.71% | -120.19% | -$3.7M |
|
BLRX
BioLineRx Ltd.
|
$225K | -$2.2M | -9.37% | -18.74% | -516.85% | -$2.1M |
|
CGEN
Compugen Ltd.
|
$241K | -$7.9M | -49.12% | -51.8% | -417.4% | -- |
|
EVGN
Evogene Ltd.
|
-$126K | -$2.7M | -57.78% | -66.95% | -870.19% | -$3.8M |
|
NNOX
Nano-X Imaging Ltd.
|
-$3M | -$14.2M | -31.33% | -32.75% | -412.88% | -$13.9M |
|
PLUR
Pluri, Inc.
|
-$15K | -$6.4M | -77.49% | -5662.45% | -2009.49% | -$5.5M |
MediWound Ltd. vs. Competitors
-
Which has Higher Returns MDWD or BLRX?
BioLineRx Ltd. has a net margin of -48.85% compared to MediWound Ltd.'s net margin of -228.81%. MediWound Ltd.'s return on equity of -61.71% beat BioLineRx Ltd.'s return on equity of -18.74%.
Company Gross Margin Earnings Per Share Invested Capital MDWDMediWound Ltd.16.5% -$0.24 $59.5M BLRXBioLineRx Ltd.52.45% -$0.22 $30.9M -
What do Analysts Say About MDWD or BLRX?
MediWound Ltd. has a consensus price target of $31.50, signalling upside risk potential of 82.61%. On the other hand BioLineRx Ltd. has an analysts' consensus of $20.33 which suggests that it could grow by 589.27%. Given that BioLineRx Ltd. has higher upside potential than MediWound Ltd., analysts believe BioLineRx Ltd. is more attractive than MediWound Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MDWDMediWound Ltd.5 0 0 BLRXBioLineRx Ltd.2 0 0 -
Is MDWD or BLRX More Risky?
MediWound Ltd. has a beta of 0.133, which suggesting that the stock is 86.712% less volatile than S&P 500. In comparison BioLineRx Ltd. has a beta of 1.321, suggesting its more volatile than the S&P 500 by 32.082%.
-
Which is a Better Dividend Stock MDWD or BLRX?
MediWound Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioLineRx Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MediWound Ltd. pays -- of its earnings as a dividend. BioLineRx Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDWD or BLRX?
MediWound Ltd. quarterly revenues are $5.4M, which are larger than BioLineRx Ltd. quarterly revenues of $429K. MediWound Ltd.'s net income of -$2.7M is lower than BioLineRx Ltd.'s net income of -$981.6K. Notably, MediWound Ltd.'s price-to-earnings ratio is -- while BioLineRx Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MediWound Ltd. is 8.95x versus 0.81x for BioLineRx Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDWDMediWound Ltd.8.95x -- $5.4M -$2.7M BLRXBioLineRx Ltd.0.81x -- $429K -$981.6K
-
Which has Higher Returns MDWD or CGEN?
Compugen Ltd. has a net margin of -48.85% compared to MediWound Ltd.'s net margin of -369.06%. MediWound Ltd.'s return on equity of -61.71% beat Compugen Ltd.'s return on equity of -51.8%.
Company Gross Margin Earnings Per Share Invested Capital MDWDMediWound Ltd.16.5% -$0.24 $59.5M CGENCompugen Ltd.12.75% -$0.07 $46.8M -
What do Analysts Say About MDWD or CGEN?
MediWound Ltd. has a consensus price target of $31.50, signalling upside risk potential of 82.61%. On the other hand Compugen Ltd. has an analysts' consensus of $5.80 which suggests that it could grow by 239.18%. Given that Compugen Ltd. has higher upside potential than MediWound Ltd., analysts believe Compugen Ltd. is more attractive than MediWound Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MDWDMediWound Ltd.5 0 0 CGENCompugen Ltd.5 0 0 -
Is MDWD or CGEN More Risky?
MediWound Ltd. has a beta of 0.133, which suggesting that the stock is 86.712% less volatile than S&P 500. In comparison Compugen Ltd. has a beta of 2.864, suggesting its more volatile than the S&P 500 by 186.386%.
-
Which is a Better Dividend Stock MDWD or CGEN?
MediWound Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Compugen Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MediWound Ltd. pays -- of its earnings as a dividend. Compugen Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDWD or CGEN?
MediWound Ltd. quarterly revenues are $5.4M, which are larger than Compugen Ltd. quarterly revenues of $1.9M. MediWound Ltd.'s net income of -$2.7M is higher than Compugen Ltd.'s net income of -$7M. Notably, MediWound Ltd.'s price-to-earnings ratio is -- while Compugen Ltd.'s PE ratio is 55.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MediWound Ltd. is 8.95x versus 22.85x for Compugen Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDWDMediWound Ltd.8.95x -- $5.4M -$2.7M CGENCompugen Ltd.22.85x 55.83x $1.9M -$7M
-
Which has Higher Returns MDWD or EVGN?
Evogene Ltd. has a net margin of -48.85% compared to MediWound Ltd.'s net margin of -874.68%. MediWound Ltd.'s return on equity of -61.71% beat Evogene Ltd.'s return on equity of -66.95%.
Company Gross Margin Earnings Per Share Invested Capital MDWDMediWound Ltd.16.5% -$0.24 $59.5M EVGNEvogene Ltd.-40.39% $0.44 $19.8M -
What do Analysts Say About MDWD or EVGN?
MediWound Ltd. has a consensus price target of $31.50, signalling upside risk potential of 82.61%. On the other hand Evogene Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 145.1%. Given that Evogene Ltd. has higher upside potential than MediWound Ltd., analysts believe Evogene Ltd. is more attractive than MediWound Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MDWDMediWound Ltd.5 0 0 EVGNEvogene Ltd.1 0 0 -
Is MDWD or EVGN More Risky?
MediWound Ltd. has a beta of 0.133, which suggesting that the stock is 86.712% less volatile than S&P 500. In comparison Evogene Ltd. has a beta of 1.352, suggesting its more volatile than the S&P 500 by 35.162%.
-
Which is a Better Dividend Stock MDWD or EVGN?
MediWound Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Evogene Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MediWound Ltd. pays -- of its earnings as a dividend. Evogene Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDWD or EVGN?
MediWound Ltd. quarterly revenues are $5.4M, which are larger than Evogene Ltd. quarterly revenues of $312K. MediWound Ltd.'s net income of -$2.7M is higher than Evogene Ltd.'s net income of -$2.7M. Notably, MediWound Ltd.'s price-to-earnings ratio is -- while Evogene Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MediWound Ltd. is 8.95x versus 1.43x for Evogene Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDWDMediWound Ltd.8.95x -- $5.4M -$2.7M EVGNEvogene Ltd.1.43x -- $312K -$2.7M
-
Which has Higher Returns MDWD or NNOX?
Nano-X Imaging Ltd. has a net margin of -48.85% compared to MediWound Ltd.'s net margin of -396.98%. MediWound Ltd.'s return on equity of -61.71% beat Nano-X Imaging Ltd.'s return on equity of -32.75%.
Company Gross Margin Earnings Per Share Invested Capital MDWDMediWound Ltd.16.5% -$0.24 $59.5M NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M -
What do Analysts Say About MDWD or NNOX?
MediWound Ltd. has a consensus price target of $31.50, signalling upside risk potential of 82.61%. On the other hand Nano-X Imaging Ltd. has an analysts' consensus of $7.40 which suggests that it could grow by 230.36%. Given that Nano-X Imaging Ltd. has higher upside potential than MediWound Ltd., analysts believe Nano-X Imaging Ltd. is more attractive than MediWound Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MDWDMediWound Ltd.5 0 0 NNOXNano-X Imaging Ltd.4 0 0 -
Is MDWD or NNOX More Risky?
MediWound Ltd. has a beta of 0.133, which suggesting that the stock is 86.712% less volatile than S&P 500. In comparison Nano-X Imaging Ltd. has a beta of 1.312, suggesting its more volatile than the S&P 500 by 31.211%.
-
Which is a Better Dividend Stock MDWD or NNOX?
MediWound Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano-X Imaging Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MediWound Ltd. pays -- of its earnings as a dividend. Nano-X Imaging Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDWD or NNOX?
MediWound Ltd. quarterly revenues are $5.4M, which are larger than Nano-X Imaging Ltd. quarterly revenues of $3.4M. MediWound Ltd.'s net income of -$2.7M is higher than Nano-X Imaging Ltd.'s net income of -$13.7M. Notably, MediWound Ltd.'s price-to-earnings ratio is -- while Nano-X Imaging Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MediWound Ltd. is 8.95x versus 11.49x for Nano-X Imaging Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDWDMediWound Ltd.8.95x -- $5.4M -$2.7M NNOXNano-X Imaging Ltd.11.49x -- $3.4M -$13.7M
-
Which has Higher Returns MDWD or PLUR?
Pluri, Inc. has a net margin of -48.85% compared to MediWound Ltd.'s net margin of -1940.51%. MediWound Ltd.'s return on equity of -61.71% beat Pluri, Inc.'s return on equity of -5662.45%.
Company Gross Margin Earnings Per Share Invested Capital MDWDMediWound Ltd.16.5% -$0.24 $59.5M PLURPluri, Inc.-4.75% -$0.65 $28.6M -
What do Analysts Say About MDWD or PLUR?
MediWound Ltd. has a consensus price target of $31.50, signalling upside risk potential of 82.61%. On the other hand Pluri, Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 220.86%. Given that Pluri, Inc. has higher upside potential than MediWound Ltd., analysts believe Pluri, Inc. is more attractive than MediWound Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MDWDMediWound Ltd.5 0 0 PLURPluri, Inc.1 0 0 -
Is MDWD or PLUR More Risky?
MediWound Ltd. has a beta of 0.133, which suggesting that the stock is 86.712% less volatile than S&P 500. In comparison Pluri, Inc. has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.181%.
-
Which is a Better Dividend Stock MDWD or PLUR?
MediWound Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pluri, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MediWound Ltd. pays -- of its earnings as a dividend. Pluri, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDWD or PLUR?
MediWound Ltd. quarterly revenues are $5.4M, which are larger than Pluri, Inc. quarterly revenues of $316K. MediWound Ltd.'s net income of -$2.7M is higher than Pluri, Inc.'s net income of -$6.1M. Notably, MediWound Ltd.'s price-to-earnings ratio is -- while Pluri, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MediWound Ltd. is 8.95x versus 20.45x for Pluri, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDWDMediWound Ltd.8.95x -- $5.4M -$2.7M PLURPluri, Inc.20.45x -- $316K -$6.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
